TY - JOUR
T1 - Continuous Nasogastric Infusion of Prostaglandin E2 in Ductus‐Dependent Congenital Heart Disease
AU - Komiyama, Osamu
AU - Osano, Mitsuru
AU - Oikawa, Tadao
AU - Morikawa, Yoshiyuki
AU - Kojima, Yoshifumi
AU - Murai, Takayasu
AU - Ishihara, Jun
AU - Tokumura, Mitsuaki
AU - Taguchi, Nobuhiko
PY - 1988/10
Y1 - 1988/10
N2 - Prostaglandin E2 (PGE2) was infused continuously through a nasogastric gavage tube in four infants with pulmonary atresia. The drug was given at a rate of 12.5–160 µg/kg/h. The duration of therapy was 7–123 days. The effects and side effects seen by this method were similar to those seen in the conventional multiple dose regimen. This method was an effective and simple way of maintaining the ductus arteriosus open, especially for a long period of time.
AB - Prostaglandin E2 (PGE2) was infused continuously through a nasogastric gavage tube in four infants with pulmonary atresia. The drug was given at a rate of 12.5–160 µg/kg/h. The duration of therapy was 7–123 days. The effects and side effects seen by this method were similar to those seen in the conventional multiple dose regimen. This method was an effective and simple way of maintaining the ductus arteriosus open, especially for a long period of time.
KW - Blalock‐Taussig shunt
KW - Ductus‐dependent congenital heart disease
KW - Prostaglandin E1 and E2
KW - Pulmonary atresia
UR - http://www.scopus.com/inward/record.url?scp=84995047888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995047888&partnerID=8YFLogxK
U2 - 10.1111/j.1442-200X.1988.tb01579.x
DO - 10.1111/j.1442-200X.1988.tb01579.x
M3 - Article
C2 - 3144905
AN - SCOPUS:84995047888
SN - 1328-8067
VL - 30
SP - 553
EP - 556
JO - Pediatrics International
JF - Pediatrics International
IS - 5
ER -